SLE is not a one-size-fits-all disease

In this Viewpoint we discuss how experimental medicine applied in the setting of clinical trials can address unmet need in the prototypic autoimmune disease systemic lupus erythematosus (SLE) to improve outcomes for patients.

Detalles Bibliográficos
Autores principales: Ehrenstein, Michael R., Shipa, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2023
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130747/
https://www.ncbi.nlm.nih.gov/pubmed/37097613
http://dx.doi.org/10.1084/jem.20230559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130747/
https://www.ncbi.nlm.nih.gov/pubmed/37097613
http://dx.doi.org/10.1084/jem.20230559

Ejemplares similares